Overview

A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.

Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
This study is to determine if Tyramine has any side effects on patients receiving 0.5mg, 1mg of Rasagiline or Placebo
Phase:
Phase 3
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Teva Pharmaceutical Industries
Treatments:
Rasagiline
Tyramine